- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.01. | Tivic Health Systems: Tivic, BARDA Discuss Entolimod for Acute Radiation Syndrome at TechWatch Meeting | 330 | ACCESS Newswire | January 26 Presentation highlighted Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposureBARDA has requested a follow-up meeting... ► Artikel lesen | |
| TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 26.01. | DealFlow Events: Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod to Commercialization at DealFlow Discovery Conference | 235 | ACCESS Newswire | CEO Presentation to Include Updates and Further Information on the Following Topics:Entolimod Cell Line Verification Success;200x Manufacturing Scale-Up with Reproducible Quality;BARDA TechWatch Engagement... ► Artikel lesen | |
| 21.01. | Tivic Health Systems: Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference | 806 | ACCESS Newswire | Presentation will Cover Recent Corporate Milestones Including Acceleration of Manufacturing Readiness for Entolimod FREMONT, CA / ACCESS Newswire / January 20, 2026 / Tivic Health Systems, Inc. (NASDAQ:TIVC)... ► Artikel lesen | |
| 20.01. | Tivic Health Systems, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 12.01. | Tivic Health Systems: Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod And Achieves Reproducible Yields, Potency and Purity | 423 | ACCESS Newswire | Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing... ► Artikel lesen | |
| 08.01. | Tivic Health Systems: Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines | 241 | ACCESS Newswire | Conference Call to be Hosted on Monday, January 12 at 1:30 PM PT/4:30 PM ET FREMONT, CA / ACCESS Newswire / January 8, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics... ► Artikel lesen | |
| 11.12.25 | Tivic Acquires Scorpius Holdings Manufacturing Assets And Secures More Than $90 Million Financing | 3 | pulse2.com | ||
| 11.12.25 | Tivic Health Systems, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 11.12.25 | Tivic Health übernimmt Produktionsanlagen und gründet CDMO-Tochtergesellschaft | 3 | Investing.com Deutsch | ||
| 11.12.25 | Tivic Health acquires manufacturing assets, launches CDMO subsidiary | 7 | Investing.com | ||
| 11.12.25 | Tivic Health Systems: Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package | 380 | ACCESS Newswire | Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity BioworksFinancing led by 3i, LP includes... ► Artikel lesen | |
| 18.11.25 | Tivic Health Systems: Tivic Secures Barda Meeting for Entolimod for Acute Radiation Syndrome | 391 | ACCESS Newswire | Meeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company... ► Artikel lesen | |
| 14.11.25 | Earnings Call: Strategiewechsel bei Tivic Health Systems belastet Ergebnis und Aktie | 1 | Investing.com Deutsch | ||
| 14.11.25 | Tivic Health Systems GAAP EPS of -$1.97, revenue of $0.15M | 4 | Seeking Alpha | ||
| 14.11.25 | Tivic Health Systems: Tivic Reports Third Quarter 2025 Financial Results | 2.050 | ACCESS Newswire | Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immunotherapeutics... ► Artikel lesen | |
| 13.11.25 | Tivic Health erzielt Fortschritte bei der Optimierung der Nervenstimulation | 1 | Investing.com Deutsch | ||
| 13.11.25 | Tivic Health optimizes nerve stimulation parameters in new study | 3 | Investing.com | ||
| 13.11.25 | Tivic Health Systems: Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation | 297 | ACCESS Newswire | The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire / November 13, 2025 / Tivic Health Systems, Inc.... ► Artikel lesen | |
| 13.11.25 | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.11.25 | Tivic Health files two new patents for cancer and bioelectronic therapies | 1 | Investing.com |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | BREAKING: Hims & Hers verschärft Preisdruck bei Novo Nordisk - Aktie beschleunigt Talfahrt | Der dänische Biopharma-Riese ist erst seit wenigen Wochen mit seinem Appetitzügler Wegovy als Tablette auf dem US-Markt und sieht sich einem massiven Preisdruck ausgesetzt. Das Telehealth-Unternehmen... ► Artikel lesen | |
| UNITEDHEALTH | 232,15 | -0,77 % | UnitedHealth: Das sieht gar nicht gut aus | Der enttäuschende Ausblick, den UnitedHealth dem Kapitalmarkt vor Kurzem an die Hand gegeben hat, und maue Aussichten für 2027 hinterlassen weitere Spuren im Aktienkurs des größten US-Krankenversicherers.... ► Artikel lesen | |
| RXSIGHT | 8,390 | +7,29 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
TIVIC HEALTH SYSTEMS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +3,37 % bei einem Aktienkurs von 0,858 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIVIC HEALTH SYSTEMS INC finden Sie auf Wallstreet Online.